The coverage of hepatitis B birth dose vaccination in Nigeria: Does the place of delivery matter?

Autor:	Olakunde BO; Department of Community Prevention and Care Services , National Agency for the Control of AIDS, Abuja 900284, Nigeria.; Center for Translation and Implementation Research, University of Nigeria, Nsukka, Enugu 410101, Nigeria., Adeyinka DA; Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Saskatoon SK S7B 5E5, Canada.; Department of Public Health, National AIDS and STI Control Programme, Federal Ministry of Health, Abuja 900211, Nigeria., Olakunde OA; Department of Disease Control and Immunization, Ondo State Primary Health Care Development Agency, Akure, Ondo 340222, Nigeria., Ogundipe T; Department of Hospital Medicine, Sentara Williamsburg Regional Medical Center, VA 23188, USA., Oladunni F; Department of Community and Family Medicine, Howard University Hospital, Washington, DC 20060, USA., Ezeanolue EE; Center for Translation and Implementation Research, University of Nigeria, Nsukka, Enugu 410101, Nigeria.; Healthy Sunrise Foundation, NV 89107, USA.
Jazyk:	angličtina
Zdroj:	Transactions of the Royal Society of Tropical Medicine and Hygiene [Trans R Soc Trop Med Hyg] 2022 Apr 04; Vol. 116 (4), pp. 359-368.
DOI:	10.1093/trstmh/trab129
Abstrakt:	Background: Hepatitis B birth dose (HepB-BD) vaccination coverage remains suboptimal in Nigeria. While evidence suggests that institutional delivery is associated with the uptake of HepB-BD vaccine, little is known about how the uptake differs by facility ownership (public or private). This study examined the HepB-BD vaccination coverage by place of delivery in Nigeria. Methods: This study is a secondary analysis of data on 6143 children aged 12-23 mo obtained from the 2018 Nigeria Demographic and Health Survey. We assessed the association between HepB-BD vaccination and the place of delivery using logistic regression models. Results: About 53% of the children received the HepB-BD vaccine. Approximately 77, 83 and 33% of those delivered at a public health facility, private health facility and at home received the HepB-BD vaccine, respectively. After controlling for child- and maternal-level factors, the odds of receiving HepB-BD vaccine were significantly lower in children delivered at a private health facility (adjusted OR [aOR]=0.77, 95% CI 0.59 to 0.99) or at home (aOR=0.48, 95% CI 0.36 to 0.63). Wealth index and region of residence were significantly associated with the receipt of HepB-BD vaccination in all three places of delivery. Conclusions: Children are less likely to receive the HepB-BD vaccine if they are delivered at a private health facility or at home. There is a need for private health sector engagement for immunization service delivery and innovative community-based interventions to reach the children delivered at home. (© The Author(s) 2021. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu